Traditional Prostate Cancer Risk Factors Do Not Predict Hormone Therapy Benefit, Study Finds

Traditional prostate cancer risk factors do not predict hormone therapy benefit, study finds

A new study led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center found that while traditional pathological features used to classify aggressive prostate cancer—such as high-grade disease, cancer extending outside the prostate and cancer involving the seminal vesicles—after surgery can help identify patients who are more likely to have worse outcomes, they do not predict who will benefit more from adding hormone therapy to postoperative radiation.

Traditional prostate cancer features fail to predict hormone therapy benefit

A new study led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center found that while traditional pathological features used to classify aggressive prostate cancer -such as high-grade disease, cancer extending outside the prostate and cancer involving the seminal vesicles- after surgery can help identify patients who are more likely to have worse outcomes, they do not predict who will benefit more from adding hormone therapy t…

Traditional prostate cancer risk factors do not predict hormone therapy benefit, UCLA-led study finds

Traditional pathological features used to classify aggressive prostate cancer—such as high-grade disease, cancer extending outside the prostate and cancer involving the seminal vesicles—after surgery do not predict who will benefit more from adding hormone therapy to postoperative radiation, according to a study led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center.  The study highlights the need for molecular biomarkers th…

Aggressive Prostate Cancer Signs May Not Reveal the Best Treatment

Doctors can learn a great deal about prostate cancer by examining the prostate after surgery. A new study, however, shows that signs of an aggressive tumor may not tell doctors which patients will gain the most from adding hormone therapy to radiation treatment. The research was led by investigators at the UCLA Health Jonsson Comprehensive […] The post Aggressive Prostate Cancer Signs May Not Reveal the Best Treatment appeared first on Knowridge…

Study: Traditional prostate cancer risks don’t predict hormone therapy

A large analysis led by researchers at the UCLA Health Jonsson Comprehensive Cancer Center has challenged a widely used assumption in postoperative prostate cancer care: the pathological features that identify patients at high risk of recurrence may not reveal who will benefit most from adding hormone therapy to radiation. The study, published in European Urology, […]

Study Finds Traditional Prostate Cancer Risk Factors Do Not Predict Hormone Therapy Benefit

UCLA study found that while traditional pathological features used to classify aggressive prostate cancer —such as high-grade disease, cancer extending outside the prostate and cancer involving the seminal vesicles— after surgery can help identify patients who are more likely to have worse outcomes, they do not predict who will benefit more from adding hormone therapy to postoperative radiation.